The Cancer Center of the Future Will Be Virtual First
2026 IBRI Global Forum: Connecting Science, Philanthropy, and Investment to Advance Medical Innovation
Marina Konopleva at LeukO 2026: Beyond Venetoclax - The Next Breakthroughs in AML Treatment
Inflammatory Breast Cancer in 2026: Evolving Diagnostic Criteria, Modern Trimodality Treatment, and the Challenge of Improving Survival
14 Papers Recommended by Wafik El-Deiry
C/Can Strengthens Palliative Care Services Across Three WHO Regions
Bogda Koczwara: Exploring the Full Spectrum of Cardiovascular Care for Cancer Survivors
Why Women Still Face Barriers at the Top of Medical Research? - CancerWorld
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
